Mysoline (Valeant Pharmaceuticals North America)
Welcome to the PulseAid listing for the Mysoline drug offered from Valeant Pharmaceuticals North America. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America |
NON-PROPRIETARY NAME: | Primidone |
SUBSTANCE NAME: | PRIMIDONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-06-24 |
END MARKETING DATE: | 0000-00-00 |
Mysoline HUMAN PRESCRIPTION DRUG Details:
Item Description | Mysoline from Valeant Pharmaceuticals North America |
LABELER NAME: | Valeant Pharmaceuticals North America |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2009-06-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66490-690_8e3319b6-61dd-4243-a9cf-b5acc34358ad |
PRODUCT NDC: | 66490-690 |
APPLICATION NUMBER: | NDA009170 |
Other PRIMIDONE Pharmaceutical Manufacturers / Labelers: